首页 | 本学科首页   官方微博 | 高级检索  
检索        

进展期结直肠癌新辅助治疗疗效评价方法的研究进展
作者姓名:詹红丽  王蓉  王雯
作者单位:1. 350025 福建 福州,联勤保障部队第九〇〇医院消化内科,福建医科大学福总临床医学院,厦门大学附属东方医院
基金项目:福建省社会发展引导性(重点)项目(2018Y0066)
摘    要:新辅助治疗可使原发肿瘤或转移病灶缩小,降低肿瘤分期,已被认为是进展期结直肠癌(ACRC)的主要治疗方式。但由于肠道为空腔脏器,原发病灶准确测量困难,新辅助治疗后的疗效评估更加困难。因此,就结直肠癌而言,目前缺乏统一的、有针对性的、效果明显的评价系统和标准。本文就ACRC新辅助治疗目前疗效评价方法做一综述。

关 键 词:结直肠癌  新辅助治疗  疗效评价  
收稿时间:2019-08-02

Advances in study on evaluation methods of neoadjuvant therapy for advanced colorectal cancer
Authors:Hongli Zhan  Rong Wang  Wen Wang
Institution:1. Department of Gastroenterology, 900 Hospital of the Joint Logistics Team, Fuzong Clinical Medical College of Fujian Medical University, Eastern Hospital Affiliated to Xiamen University, Fuzhou 350025, China
Abstract:The primary or metastatic tumor, even the tumor stage may be reduced after neoadjuvant therapy, and it has been considered as the main treatment for advanced colorectal cancer(ACRC). However, the accurate measurement of the primary lesion in hollow organ, such as the intestine, is difficult, so as the evaluation of the therapeutic effect after neoadjuvant therapy.Therefore, there is no unified, targeted, and effective evaluation systems and standards for colorectal cancer, and this article reviews the current efficacy evaluation methods of ACRC neoadjuvant therapy.
Keywords:Colorectal cancer  Neoadjuvant therapy  Therapeutic evaluation  
点击此处可从《》浏览原始摘要信息
点击此处可从《》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号